Status:

ACTIVE_NOT_RECRUITING

RANKL Inhibition and Mammographic Breast Density

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Dense Breasts

Eligibility:

FEMALE

40+ years

Phase:

PHASE2

Brief Summary

Data supporting a role for RANKL signaling in mammographic density and breast cancer development has begun to emerge, but clinical trial data providing definitive evidence that would allow the adoptio...

Eligibility Criteria

Inclusion

  • Female.
  • Premenopausal (when menopausal status is uncertain, the investigators will measure follicle-stimulating hormone and estradiol to ascertain that a partcipant is premenopausal)
  • At least 40 years of age.
  • Dense breasts on routine mammogram (BI-RADS Category C and D)
  • Able to understand and willing to sign an IRB-approved written informed consent document.

Exclusion

  • History of breast or any other invasive cancer except for DCIS (ductal carcinoma in situ) who received only lumpectomy, LCIS (lobular carcinoma in situ), atypical hyperplasia, non-melanoma skin cancer, carcinoma in situ of the cervix.
  • Current use of tamoxifen, aromatase inhibitors, or bisphosphonates, or RANKL inhibitors
  • Concurrent participation in another cancer chemoprevention trial (unless no longer receiving the intervention).
  • Pregnant, lactating, or planning to get pregnant while the trial is ongoing.
  • Recent history of invasive dental procedure (e.g. tooth extraction, dental implant, oral surgery).
  • Unhealed and/or planned dental/oral surgery.
  • History of osteonecrosis/osteomyelitis of the jaw.
  • History of osteoporosis or severe osteopenia.

Key Trial Info

Start Date :

August 27 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2026

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT04067726

Start Date

August 27 2019

End Date

August 31 2026

Last Update

October 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

RANKL Inhibition and Mammographic Breast Density | DecenTrialz